Maximilian Mossner

3.5k total citations · 1 hit paper
33 papers, 1.7k citations indexed

About

Maximilian Mossner is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Maximilian Mossner has authored 33 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 17 papers in Molecular Biology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Maximilian Mossner's work include Acute Myeloid Leukemia Research (17 papers), Acute Lymphoblastic Leukemia research (9 papers) and Epigenetics and DNA Methylation (7 papers). Maximilian Mossner is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), Acute Lymphoblastic Leukemia research (9 papers) and Epigenetics and DNA Methylation (7 papers). Maximilian Mossner collaborates with scholars based in Germany, United States and United Kingdom. Maximilian Mossner's co-authors include Daniel Nowak, Eckhard Thiel, Gero Hütter, Igor Wolfgang Blau, Jörg Hofmann, Wolf K. Hofmann, Olga Blau, Susanne Ganepola, Thomas Schneider and Kristina Allers and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Blood.

In The Last Decade

Maximilian Mossner

32 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation

2009 1.3k citations Gero Hütter, Daniel Nowak et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maximilian Mossner Germany	14	848	623	507	384	248	33	1.7k
Olga Blau Germany	14	851 1.0×	645 1.0×	513 1.0×	504 1.3×	229 0.9×	39	1.9k
Daniel Goff United States	10	627 0.7×	577 0.9×	225 0.4×	422 1.1×	64 0.3×	22	1.4k
Kathrin Rieger Germany	16	388 0.5×	291 0.5×	215 0.4×	448 1.2×	116 0.5×	32	1.4k
Maria Bettinotti United States	25	675 0.8×	404 0.6×	311 0.6×	1.4k 3.8×	182 0.7×	52	2.2k
Andrew McMichael United Kingdom	17	529 0.6×	364 0.6×	263 0.5×	833 2.2×	119 0.5×	25	1.5k
Lela Kardava United States	23	325 0.4×	462 0.7×	232 0.5×	1.2k 3.2×	216 0.9×	36	2.0k
Nobuaki Shimizu Japan	20	343 0.4×	487 0.8×	194 0.4×	310 0.8×	90 0.4×	77	1.6k
Sylvie Delassus France	15	390 0.5×	402 0.6×	252 0.5×	513 1.3×	108 0.4×	20	1.3k
P. Krausa United Kingdom	16	570 0.7×	382 0.6×	320 0.6×	1.8k 4.6×	176 0.7×	31	2.6k
Hiroko Tomiyama Japan	21	561 0.7×	543 0.9×	196 0.4×	1.3k 3.5×	85 0.3×	35	2.1k

Countries citing papers authored by Maximilian Mossner

Since Specialization

Citations

This map shows the geographic impact of Maximilian Mossner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maximilian Mossner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maximilian Mossner more than expected).

Fields of papers citing papers by Maximilian Mossner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maximilian Mossner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maximilian Mossner. The network helps show where Maximilian Mossner may publish in the future.

Co-authorship network of co-authors of Maximilian Mossner

This figure shows the co-authorship network connecting the top 25 collaborators of Maximilian Mossner. A scholar is included among the top collaborators of Maximilian Mossner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maximilian Mossner. Maximilian Mossner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lakatos, Eszter, Weini Huang, Maximilian Mossner, et al.. (2025). Adaptive Therapy Exploits Fitness Deficits in Chemotherapy-Resistant Ovarian Cancer to Achieve Long-Term Tumor Control. Cancer Research. 85(18). 3503–3517. 2 indexed citations

Lucchini, Sara, James Nicholson, Xinyu Zhang, et al.. (2025). A novel model of glioblastoma recurrence to identify therapeutic vulnerabilities. EMBO Molecular Medicine. 17(6). 1325–1354. 1 indexed citations

Mossner, Maximilian, Christopher Kimberley, C. Barnes, et al.. (2025). Quantitative measurement of phenotype dynamics during cancer drug resistance evolution using genetic barcoding. Nature Communications. 16(1). 5282–5282.

Lakatos, Eszter, et al.. (2021). LiquidCNA: Tracking subclonal evolution from longitudinal liquid biopsies using somatic copy number alterations. iScience. 24(8). 102889–102889. 7 indexed citations

Jann, Johann-Christoph, Maximilian Mossner, Vladimir Riabov, et al.. (2021). Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivo. Nature Communications. 12(1). 6170–6170. 12 indexed citations

Mossner, Maximilian, Ann‐Marie Baker, & Trevor A. Graham. (2021). The role of single-cell sequencing in studying tumour evolution. PubMed. 10. 49–49. 1 indexed citations

Boch, Tobias, Thomas Luft, Georgia Metzgeroth, et al.. (2018). Safety and efficacy of the CD95-ligand inhibitor asunercept in transfusion-dependent patients with low and intermediate risk MDS. Leukemia Research. 68. 62–69. 12 indexed citations

Fransecky, Lars, Martín Neumann, Sandra Heesch, et al.. (2016). Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL. Journal of Hematology & Oncology. 9(1). 95–95. 16 indexed citations

Schwaab, Juliana, Christian Dietz, Benjamin Hanfstein, et al.. (2014). Expression of transketolase-like gene 1 (TKTL1) depends on disease phase in patients with chronic myeloid leukaemia (CML). Journal of Cancer Research and Clinical Oncology. 140(3). 411–417. 3 indexed citations

10.

Nowak, Daniel, Natalia Liem, Maximilian Mossner, et al.. (2014). Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance. Experimental Hematology. 43(1). 32–43.e35. 17 indexed citations

11.

Schwaab, Juliana, Thomas Ernst, Philipp Erben, et al.. (2012). Activating CBL mutations are associated with a distinct MDS/MPN phenotype. Annals of Hematology. 91(11). 1713–1720. 29 indexed citations

12.

Mossner, Maximilian, Martín Neumann, Uwe Platzbecker, et al.. (2010). Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS. Leukemia Research. 34(12). 1610–1616. 31 indexed citations

13.

Heesch, Sandra, Isabelle Bartram, Martín Neumann, et al.. (2010). Expression of IGFBP7 in acute leukemia is regulated by DNA methylation. Cancer Science. 102(1). 253–259. 17 indexed citations

14.

Hütter, Gero, Martin Kaiser, Martín Neumann, et al.. (2010). Epigenetic regulation of PAX5 expression in acute T-cell lymphoblastic leukemia. Leukemia Research. 35(5). 614–619. 14 indexed citations

15.

Mossner, Maximilian, Daniel Nowak, Verena Nowak, et al.. (2010). Detection of Highly Clonal CD34+, Mononuclear Bone Marrow and Peripheral Blood Cells From Patients with Myelodysplastic Syndrome and Age Related Increase of Clonal Hematopoiesis In Healthy Subjects Using a Novel Transcriptional Pyrosequencing Based Clonality Assay. Blood. 116(21). 977–977. 1 indexed citations

16.

Hütter, Gero, Daniel Nowak, Maximilian Mossner, et al.. (2009). Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation. New England Journal of Medicine. 360(7). 692–698. 1250 indexed citations breakdown →

17.

Nowak, Daniel, Florian Nolte, Maximilian Mossner, et al.. (2009). Genome-wide DNA-mapping of CD34+ cells from patients with myelodysplastic syndrome using 500K SNP arrays identifies significant regions of deletion and uniparental disomy. Experimental Hematology. 37(2). 215–224.e2. 13 indexed citations

18.

Baldus, Claudia D., Nicola Goekbuget, Andrea Stroux, et al.. (2009). Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia. Haematologica. 94(10). 1383–1390. 61 indexed citations

19.

Schlee, Cornelia, Maximilian Mossner, Sandra Heesch, et al.. (2008). Epigenetic control of differential expression of specific ERG isoforms in acute T-lymphoblastic leukemia. Leukemia Research. 33(6). 817–822. 13 indexed citations

20.

Nowak, Daniel, Maximilian Mossner, Claudia D. Baldus, et al.. (2006). Mutation Analysis of hCDC4 in AML Cells Identifies a New Intronic Polymorphism. International Journal of Medical Sciences. 3(4). 148–151. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact